増強ボーングラフト(骨移植)の世界市場予測

◆英語タイトル:Augmented Bone Graft Market Research Report- Global Forecast till 2023
◆商品コード:MRF801066
◆発行会社(調査会社):Market Research Future
◆発行日:2018年1月
◆ページ数:100
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:産業未分類
◆販売価格オプション(消費税別)
Single User(印刷不可)USD4,450 ⇒換算¥489,500見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD6,250 ⇒換算¥687,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
Market Research Futureが出版した本調査レポートでは、増強ボーングラフト(骨移植)の世界市場について調査・分析し、増強ボーングラフト(骨移植)の世界市場動向、市場予測、セグメント別分析(製品別(同種移植片、骨補填材、Cell-based Matrice)、用途別(Craniomaxillofacial、歯科、足・足首、関節再建、長管骨、脊椎固定)、最終用途別(病院、クリニック、通院外科診療所(ASC)、その他))、主要地域別分析(アメリカ市場、ヨーロッパ市場、アジア市場)、世界市場規模、関連企業分析などを含め、以下の構成でお届けいたします。
【レポートの概要】

Augmented Bone Graft Market Research Report by product (Allografts, Bone Grafts Substitutes, Cell-based Matrices), application (Craniomaxillofacial, Dental, Foot & Ankle, Joint Reconstruction, Long Bone, Spinal Fusion), end user– Global forecast till 2023Market Scenario

Augmented Bone Grafts are gaining prominence in the bone graft market. The increasing incidence of musculoskeletal conditions and technological advancements in medical devices leading to shift from autograft to allograft procedures are some factors responsible for the growth of the global augmented bone grafts market.

Augment Bone Graft is a combination drug/device product used for repairing the bone and reviving its regenerative properties. It is used as an alternative to autograft in arthrodesis of the ankle or hindfoot indicating the need for supplemental graft material. The use of augment bone graft eliminates the need for a second surgery to harvest autologous bone, thereby avoiding donor site morbidity. According to the National Health Interview Survey, in 2012, around 126 million adults were affected by this disease in the U.S. According to the Labor Force Survey (LFS), about 553,000 cases were registered for all work-related musculoskeletal disorder out of the total of 1,243,000 cases.

Allografts and bovine-derived bone graft products dominate the augmented bone graft market. These materials have variations in particle size which is their main drawback. The recent technological trend is to replace these natural materials with alloplastic bone grafts such as ceramics and polymers as they can be manufactured to the precise size and characteristics.

According to the British Editorial Society of Bone & Joint Surgery, bone is the second most common transplanted tissue after blood with an estimated 2.2 million grafting procedures worldwide annually as recorded in 2015. This development has been fuelled by the increasing cases of fractures and accidents around the world. There has been increasing acceptance of bone grafting procedures which drives the market for augmented bone graft products. Many healthcare professionals have started using these bone grafts, especially in tertiary care centers and specialty hospitals which may promote and increase the demand for augmented bone graft. These bone graft works in a unique way to stimulate three key processes of early bone healing.

Various other factors such as, increasing advancement in technology, and rising adoption rate of new technology continuously contribute to the growth of this market. Despite these developments, high cost of surgeries and ethical issues related with bone grafting procedures may hamper the growth of the market. For instance, a study conducted by BMC Medical Ethics states that in a sample of 100 patients, about 20% of the patients refuse to accept allografts for their grafting surgery.

Additionally, stringent regulations obstruct the growth of bone grafts market and inadequate reimbursement policies for bone grafting also hampers the growth of global bone grafts market. Rapid product launches and increasing mergers and acquisitions between bone graft systems manufacturing companies are some of the major trends in the global bone grafts market.

The Global market of Augmented Bone Graft is expected to grow at a CAGR of approximately 7.8% during the forecast period 2017-2023.

Intended Audience

Augmented Bone Graft Suppliers
Augmented Bone Graft Manufacturers
Research and Development (R&D) Companies
Medical Research Laboratories
Academic Medical Institutes and Universities
Segmentation

The Augmented Bone Graft is segmented on the basis of products, application, and end-users.

On the basis of product, the market is segmented into the Allografts, Bone Grafts Substitutes, and Cell-based Matrices. The Allografts segment is further sub divided into Machined Allografts and Demineralized Bone Matrix. The Bone Grafts Substitutes is also sub categorized as Bone Morphogenic Proteins (BMP) and Synthetic Bone Grafts.

On the basis of application, the market is segmented into the Craniomaxillofacial, Dental, Foot & Ankle, Joint Reconstruction, Long Bone, and Spinal Fusion

On the basis of end-user, the market is segmented into hospitals, clinics, ambulatory surgical centers and others.

Regional Analysis

The Global Augmented Bone Graft Market consists of countries namely America, Europe, Asia Pacific, and the Middle East.

North America dominated the global augmented bone graft market owing to the increasing healthcare expenditure in North America since 2016. Canadian healthcare specifically was stressed by an advancing demographic move. The increase of insurance coverage because of health care reform (Affordable Care Act) in the United States additionally prompted an expansion in health care spending. In 2016, healthcare organizations found liberation from a special tax on medical devices (Medical Device Excise Tax). The United States Congress put off the tax for a long two years in 2015.

For Europe, the healthcare spending has expanded slightly in Germany. Neverthelss, the orthopedic biologics market including the bone graft substitute market has been determined by solid strong competition and price pressure. While volume of sales and the scope of new treatment techniques are on the ascent, net revenues in the German market are declining. Western Europe continues to see a need to save money on healthcare because of a slight drop in financial growth and obstinate economic pressure.

Healthcare spending in Asia expanded in 2016 due to an extension of state health care programs and the increasing affluence of the population. India, in specific, saw an expansion in spending due to a government resolution to enhance healthcare services.

Furthermore in the Middle East & Africa the spending for healthcare was also increased. This was essentially because of elections in a few nations, (for example, Ghana, Niger, Uganda, Zambia and Somalia), healthcare growth and population growth. Awareness for medicinal technology likewise expanded extraordinarily. Due to of low local production, the region is dependent on imported medicinal products. The import standard in numerous nations is 80% to 90%.

Key Players

Many new companies have jumped into the market in order to make the most out of the opportunities. Companies are implementing the strategies of mergers and acquisitions with other players. For example, the Stryker Corporation, in order to enhance its business, acquired companies such as Novadaq Technologies Inc. in 2017, Stanmore Implants Worldwide Limited, Physio-Control International Inc, & Vertebral compression fracture portfolio from BD in 2016; and some other companies in the recent past.

Some of key the players in the Global Augmented Bone Graft Market are Zimmer Holdings, Inc., BioMimetic Therapeutics LLC, Wright Medical Technology, Inc., Stryker Corporation, Smith & Nephew Plc, RTI Surgical, Inc., Olympus Biotech Corporation, NuVasive, Inc., NovaBone Products LLC, Medtronic, Inc., LifeNet Health, Inc., Integra LifeSciences Holdings Corporation, Exactech, Inc., DePuy Spine, Inc., Synthes Inc., DePuy Synthes Companies, Biomet, Inc. and AlloSource.

【レポートの目次】

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Augmented Bone Graft Market, By Imaging Modality

6.1 Introduction

6.2 Allografts

6.2.1 Market Estimates & Forecast, 2016 – 2023

6.3 Bone Grafts Substitutes

6.3.1 Market Estimates & Forecast, 2016 – 2023

6.4 Cell-Based Matrices

6.4.1 Market Estimates & Forecast, 2016 – 2023

Chapter 7. Global Augmented Bone Graft Market, By Applications

7.1 Introduction

7.2 Craniomaxillofacial

7.2.1 Market Estimates & Forecast, 2017 – 2023

7.3 Dental

7.3.1 Market Estimates & Forecast, 2017 – 2023

7.4 Foot & Ankle

7.4.1 Market Estimates & Forecast, 2017 – 2023

7.5 Joint Reconstruction

7.5.1 Market Estimates & Forecast, 2017 – 2023

7.6 Long Bone

7.6.1 Market Estimates & Forecast, 2017 – 2023

7.7 Spinal Fusion

7.7.1 Market Estimates & Forecast, 2017 – 2023

Chapter 8. Global Augmented Bone Graft Market, By End User

8.1 Introduction

8.2 Hospitals

8.2.1 Market Estimates & Forecast, 2017 – 2023

8.3 Clinics

8.3.2 Market Estimates & Forecast, 2017 – 2023

8.4 Ambulatory Surgical Centers

8.4.2 Market Estimates & Forecast, 2017 – 2023

8.5 Others

8.5.2 Market Estimates & Forecast, 2017 – 2023

Chapter .9 Global Augmented Bone Graft Market, By Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 U.S.

9.2.1.1 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 U.K

9.3.1.6 Rest Of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic Of Korea

9.4.6 Rest Of Asia Pacific

9.5 The Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest Of The Middle East & Africa

Chapter 10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

Chapter 11 Company Profiles

11.1 Wright Medical Group

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 Zimmer Holdings, Inc.

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 BioMimetic Therapeutics LLC

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Stryker Corporation

11.4.1 Company Overview

11.4.2 Product/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 NovaBone Products LLC

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial Overview

11.5.4 Key Developments

11.6 RTI Surgical, Inc.

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.7 Olympus Biotech Corporation.

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 NuVasive, Inc.

11.8.1 Company Overview

11.8.2 Product/Business Segment Overview

11.8.3 Financial Overview

11.8.4 Key Development

11.8.5 SWOT Analysis

11.9 Smith & Nephew Plc

11.9.1 Company Overview

11.9.2 Product Overview

11.9.3 Financial Overview

11.9.4 Key Developments

11.10 Others

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs Of The Market

12.2 Key Companies To Watch

12.3 Prediction Of Pharmaceutical Industry

Chapter 13 Appendix

LIST OF TABLES

Table 1 Augmented Bone Graft Industry Synopsis, 2017 – 2023

Table 2 Augmented Bone Graft Market Estimates And Forecast, 2017 – 2023, (USD Million)

Table 3 Augmented Bone Graft Market By Region, 2017 – 2023, (USD Million)

Table 4 Augmented Bone Graft Market By Diagnosis, 2017 – 2023, (USD Million)

Table 5 Augmented Bone Graft Market By Treatment, 2017 – 2023, (USD Million)

Table 6 Augmented Bone Graft Market By End Users, 2017 – 2023, (USD Million)

Table 7 North America Augmented Bone Graft Market By Diagnosis, 2017 – 2023, (USD Million)

Table 8 North America Augmented Bone Graft Market By Treatment, 2017 – 2023, (USD Million)

Table 9 North America Augmented Bone Graft Market By End Users, 2017 – 2023, (USD Million)

Table 10 US Augmented Bone Graft Market By Diagnosis, 2017 – 2023, (USD Million)

Table 11 US Augmented Bone Graft Market By Treatment, 2017 – 2023, (USD Million)

Table 12 US Augmented Bone Graft Market By End Users, 2017 – 2023, (USD Million)

Table 13 Canada Augmented Bone Graft Market By Diagnosis, 2017 – 2023, (USD Million)

Table 14 Canada Augmented Bone Graft Market By Treatment, 2017 – 2023, (USD Million)

Table 15 Canada Augmented Bone Graft Market By End Users, 2017 – 2023, (USD Million)

Table 16 South America Augmented Bone Graft Market By Diagnosis, 2017 – 2023, (USD Million)

Table 17 South America Augmented Bone Graft Market By Treatment, 2017 – 2023, (USD Million)

Table 18 South America Augmented Bone Graft Market By End Users, 2017 – 2023, (USD Million)

Table 19 Europe Augmented Bone Graft Market By Diagnosis, 2017 – 2023, (USD Million)

Table 20 Europe Augmented Bone Graft Market By Treatment, 2017 – 2023, (USD Million)

Table 21 Europe Augmented Bone Graft Market By End Users, 2017 – 2023, (USD Million)

Table 22 Western Europe Augmented Bone Graft Market By Diagnosis, 2017 – 2023, (USD Million)

Table 23 Western Europe Augmented Bone Graft Market By Treatment, 2017 – 2023, (USD Million)

Table 24 Western Europe Augmented Bone Graft Market By End Users, 2017 – 2023, (USD Million)

Table 25 Eastern Europe Augmented Bone Graft Market By Diagnosis, 2017 – 2023, (USD Million)

Table 26 Eastern Europe Augmented Bone Graft Market By Treatment, 2017 – 2023, (USD Million)

Table 27 Eastern Europe Augmented Bone Graft Market By End Users, 2017 – 2023, (USD Million)

Table 28 Asia Pacific Augmented Bone Graft Market By Diagnosis, 2017 – 2023, (USD Million)

Table 29 Asia Pacific Augmented Bone Graft Market By Treatment, 2017 – 2023, (USD Million)

Table 30 Asia Pacific Augmented Bone Graft Market By End Users, 2017 – 2023, (USD Million)

Table 31 Middle East & Africa Augmented Bone Graft Market By Diagnosis, 2017 – 2023, (USD Million)

Table 32 Middle East & Africa Augmented Bone Graft Market By Treatment, 2017 – 2023, (USD Million)

Table 33 Middle East & Africa Augmented Bone Graft Market By End Users, 2017 – 2023, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation For Augmented Bone Graft Market

Figure 3 Segmentation Market Dynamics For Augmented Bone Graft Market

Figure 4 Global Augmented Bone Graft Market Share, By Diagnosis 2016

Figure 5 Global Augmented Bone Graft Market Share, By Treatment 2016

Figure 6 Global Augmented Bone Graft Market Share, By End Users, 2016

Figure 7 Global Augmented Bone Graft Market Share, By Region, 2016

Figure 8 North America Augmented Bone Graft Market Share, By Country, 2016

Figure 9 Europe Augmented Bone Graft Market Share, By Country, 2016

Figure 10 Asia Pacific Augmented Bone Graft Market Share, By Country, 2016

Figure 11 Middle East & Africa Augmented Bone Graft Market Share, By Country, 2016

Figure 12 Global Augmented Bone Graft Market: Company Share Analysis, 2016 (%)

Figure 13 Wright Medical Technology, Inc.: Key Financials

Figure 14 Wright Medical Technology, Inc.: Segmental Revenue

Figure 15 Wright Medical Technology, Inc.: Geographical Revenue

Figure 16 Zimmer Holdings, Inc.: Key Financials

Figure 17 Zimmer Holdings, Inc.: Segmental Revenue

Figure 18 Zimmer Holdings, Inc.: Geographical Revenue

Figure 19 BioMimetic Therapeutics LLC: Key Financials

Figure 20 BioMimetic Therapeutics LLC: Segmental Revenue

Figure 21 BioMimetic Therapeutics LLC: Geographical Revenue

Figure 22 Stryker Corporation: Key Financials

Figure 23 Stryker Corporation: Segmental Revenue

Figure 24 Stryker Corporation: Geographical Revenue

Figure 25 RTI Surgical, Inc: Key Financials

Figure 26 RTI Surgical, Inc: Segmental Revenue

Figure 27 RTI Surgical, Inc: Geographical Revenue

Figure 28 Olympus Biotech Corporation: Key Financials

Figure 29 Olympus Biotech Corporation: Segmental Revenue

Figure 30 Olympus Biotech Corporation: Geographical Revenue

Figure 31 NuVasive, Inc.: Key Financials

Figure 32 NuVasive, Inc.: Segmental Revenue

Figure 33 NuVasive, Inc.: Geographical Revenue

Figure 34 NovaBone Products LLC: Key Financials

Figure 35 NovaBone Products LLC: Segmental Revenue

Figure 36 NovaBone Products LLC: Geographical Revenue

Figure 37 Smith & Nephew Plc: Key Financials

Figure 38 Smith & Nephew Plc: Segmental Revenue

Figure 39 Smith & Nephew Plc: Geographical Revenue

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.7 Olympus Biotech Corporation.

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 NuVasive, Inc.

11.8.1 Company Overview

11.8.2 Product/Business Segment Overview

11.8.3 Financial Overview

11.8.4 Key Development

11.8.5 SWOT Analysis

11.9 Smith & Nephew Plc

11.9.1 Company Overview

11.9.2 Product Overview

11.9.3 Financial Overview

11.9.4 Key Developments

11.10 Others

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs Of The Market

12.2 Key Companies To Watch

12.3 Prediction Of Pharmaceutical Industry

Chapter 13 Appendix

LIST OF TABLES

Table 1 Augmented Bone Graft Industry Synopsis, 2017 – 2023

Table 2 Augmented Bone Graft Market Estimates And Forecast, 2017 – 2023, (USD Million)

Table 3 Augmented Bone Graft Market By Region, 2017 – 2023, (USD Million)

Table 4 Augmented Bone Graft Market By Diagnosis, 2017 – 2023, (USD Million)

Table 5 Augmented Bone Graft Market By Treatment, 2017 – 2023, (USD Million)

Table 6 Augmented Bone Graft Market By End Users, 2017 – 2023, (USD Million)

Table 7 North America Augmented Bone Graft Market By Diagnosis, 2017 – 2023, (USD Million)

Table 8 North America Augmented Bone Graft Market By Treatment, 2017 – 2023, (USD Million)

Table 9 North America Augmented Bone Graft Market By End Users, 2017 – 2023, (USD Million)

Table 10 US Augmented Bone Graft Market By Diagnosis, 2017 – 2023, (USD Million)

Table 11 US Augmented Bone Graft Market By Treatment, 2017 – 2023, (USD Million)

Table 12 US Augmented Bone Graft Market By End Users, 2017 – 2023, (USD Million)

Table 13 Canada Augmented Bone Graft Market By Diagnosis, 2017 – 2023, (USD Million)

Table 14 Canada Augmented Bone Graft Market By Treatment, 2017 – 2023, (USD Million)

Table 15 Canada Augmented Bone Graft Market By End Users, 2017 – 2023, (USD Million)

Table 16 South America Augmented Bone Graft Market By Diagnosis, 2017 – 2023, (USD Million)

Table 17 South America Augmented Bone Graft Market By Treatment, 2017 – 2023, (USD Million)

Table 18 South America Augmented Bone Graft Market By End Users, 2017 – 2023, (USD Million)

Table 19 Europe Augmented Bone Graft Market By Diagnosis, 2017 – 2023, (USD Million)

Table 20 Europe Augmented Bone Graft Market By Treatment, 2017 – 2023, (USD Million)

Table 21 Europe Augmented Bone Graft Market By End Users, 2017 – 2023, (USD Million)

Table 22 Western Europe Augmented Bone Graft Market By Diagnosis, 2017 – 2023, (USD Million)

Table 23 Western Europe Augmented Bone Graft Market By Treatment, 2017 – 2023, (USD Million)

Table 24 Western Europe Augmented Bone Graft Market By End Users, 2017 – 2023, (USD Million)

Table 25 Eastern Europe Augmented Bone Graft Market By Diagnosis, 2017 – 2023, (USD Million)

Table 26 Eastern Europe Augmented Bone Graft Market By Treatment, 2017 – 2023, (USD Million)

Table 27 Eastern Europe Augmented Bone Graft Market By End Users, 2017 – 2023, (USD Million)

Table 28 Asia Pacific Augmented Bone Graft Market By Diagnosis, 2017 – 2023, (USD Million)

Table 29 Asia Pacific Augmented Bone Graft Market By Treatment, 2017 – 2023, (USD Million)

Table 30 Asia Pacific Augmented Bone Graft Market By End Users, 2017 – 2023, (USD Million)

Table 31 Middle East & Africa Augmented Bone Graft Market By Diagnosis, 2017 – 2023, (USD Million)

Table 32 Middle East & Africa Augmented Bone Graft Market By Treatment, 2017 – 2023, (USD Million)

Table 33 Middle East & Africa Augmented Bone Graft Market By End Users, 2017 – 2023, (USD Million)





LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation For Augmented Bone Graft Market

Figure 3 Segmentation Market Dynamics For Augmented Bone Graft Market

Figure 4 Global Augmented Bone Graft Market Share, By Diagnosis 2016

Figure 5 Global Augmented Bone Graft Market Share, By Treatment 2016

Figure 6 Global Augmented Bone Graft Market Share, By End Users, 2016

Figure 7 Global Augmented Bone Graft Market Share, By Region, 2016

Figure 8 North America Augmented Bone Graft Market Share, By Country, 2016

Figure 9 Europe Augmented Bone Graft Market Share, By Country, 2016

Figure 10 Asia Pacific Augmented Bone Graft Market Share, By Country, 2016

Figure 11 Middle East & Africa Augmented Bone Graft Market Share, By Country, 2016

Figure 12 Global Augmented Bone Graft Market: Company Share Analysis, 2016 (%)

Figure 13 Wright Medical Technology, Inc.: Key Financials

Figure 14 Wright Medical Technology, Inc.: Segmental Revenue

Figure 15 Wright Medical Technology, Inc.: Geographical Revenue

Figure 16 Zimmer Holdings, Inc.: Key Financials

Figure 17 Zimmer Holdings, Inc.: Segmental Revenue

Figure 18 Zimmer Holdings, Inc.: Geographical Revenue

Figure 19 BioMimetic Therapeutics LLC: Key Financials

Figure 20 BioMimetic Therapeutics LLC: Segmental Revenue

Figure 21 BioMimetic Therapeutics LLC: Geographical Revenue

Figure 22 Stryker Corporation: Key Financials

Figure 23 Stryker Corporation: Segmental Revenue

Figure 24 Stryker Corporation: Geographical Revenue

Figure 25 RTI Surgical, Inc: Key Financials

Figure 26 RTI Surgical, Inc: Segmental Revenue

Figure 27 RTI Surgical, Inc: Geographical Revenue

Figure 28 Olympus Biotech Corporation: Key Financials

Figure 29 Olympus Biotech Corporation: Segmental Revenue

Figure 30 Olympus Biotech Corporation: Geographical Revenue

Figure 31 NuVasive, Inc.: Key Financials

Figure 32 NuVasive, Inc.: Segmental Revenue

Figure 33 NuVasive, Inc.: Geographical Revenue

Figure 34 NovaBone Products LLC: Key Financials

Figure 35 NovaBone Products LLC: Segmental Revenue

Figure 36 NovaBone Products LLC: Geographical Revenue

Figure 37 Smith & Nephew Plc: Key Financials

Figure 38 Smith & Nephew Plc: Segmental Revenue

Figure 39 Smith & Nephew Plc: Geographical Revenue

★調査レポート[増強ボーングラフト(骨移植)の世界市場予測] (コード:MRF801066)販売に関する免責事項を必ずご確認ください。
★調査レポート[増強ボーングラフト(骨移植)の世界市場予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆